Clinical Trial: Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06945237) titled 'Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease' on April 18.

Brief Summary: Gastroesophageal reflux disease (GERD) is a common chronic digestive system disorder with a high prevalence and a notably increasing trend. It imposes significant costs in terms of treatment expenses and impacts patients' quality of life. Acid suppression remains the primary treatment for GERD. However, numerous clinical studies have shown that 20-30% of patients still exhibit poor response to proton pump inhibitors (PPIs) even after completing a standard course of acid-suppressive therapy. Many studies have demons...